Report overview
Antiviral drugs are a class of drugs for the specific treatment of viral infections.
This report contains market size and forecasts of Influenza (Flu) Antiviral Drugs in Global, including the following market information:
Global Influenza (Flu) Antiviral Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Influenza (Flu) Antiviral Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Penetration and Dehulling Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Influenza (Flu) Antiviral Drugs include Pfizer, Roche, Sanofi, Johnson & Johnson, Merck & Co. (MSD), Novartis, AbbVie, Gilead Sciences and GlaxoSmithKline (GSK), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Influenza (Flu) Antiviral Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Influenza (Flu) Antiviral Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Influenza (Flu) Antiviral Drugs Market Segment Percentages, by Type, 2021 (%)
Penetration and Dehulling Inhibitors
DNA Polymerase Inhibitors
Reverse Transcriptase Inhibitors
Protein Inhibitors
Neuraminidase Inhibitors
Broad-spectrum Antiviral Drugs
Global Influenza (Flu) Antiviral Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Influenza (Flu) Antiviral Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Household
Others
Global Influenza (Flu) Antiviral Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Influenza (Flu) Antiviral Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Influenza (Flu) Antiviral Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Influenza (Flu) Antiviral Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
Allergan
Takeda
Boehringer Ingelheim
